XML 19 R6.htm IDEA: XBRL DOCUMENT v3.22.2.2
CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Common Stock
Additional Paid-in Capital
Additional Paid-in Capital
Cumulative Effect, Period of Adoption, Adjustment
Retained Earnings (Deficit)
Retained Earnings (Deficit)
Cumulative Effect, Period of Adoption, Adjustment
Accumulated Other Comprehensive Loss
Beginning balance (in shares) at Dec. 31, 2020     30,874          
Beginning balance at Dec. 31, 2020 $ 214,603   $ 9,257 $ 422,589   $ (189,565)   $ (27,678)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net loss (34,291)         (34,291)    
Foreign currency translation adjustment, net of tax 319             319
Non-cash compensation 2,330     2,330        
Net settlement of vested stock awards (in shares)     19          
Net settlement of vested stock awards (101)   $ 6 (107)        
Ending balance (in shares) at Mar. 31, 2021     30,893          
Ending balance at Mar. 31, 2021 182,860   $ 9,263 424,812   (223,856)   (27,359)
Beginning balance (in shares) at Dec. 31, 2020     30,874          
Beginning balance at Dec. 31, 2020 214,603   $ 9,257 422,589   (189,565)   (27,678)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net loss [1] (142,966)              
Ending balance (in shares) at Sep. 30, 2021     30,980          
Ending balance at Sep. 30, 2021 75,437   $ 9,289 428,031   (332,531)   (29,352)
Beginning balance (in shares) at Mar. 31, 2021     30,893          
Beginning balance at Mar. 31, 2021 182,860   $ 9,263 424,812   (223,856)   (27,359)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net loss (17,493)         (17,493)    
Foreign currency translation adjustment, net of tax 400             400
Non-cash compensation 2,138     2,138        
Net settlement of vested stock awards (in shares)     86          
Net settlement of vested stock awards 0   $ 26 (26)        
Ending balance (in shares) at Jun. 30, 2021     30,979          
Ending balance at Jun. 30, 2021 167,905   $ 9,289 426,924   (241,349)   (26,959)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net loss (91,182)         (91,182)    
Foreign currency translation adjustment, net of tax (2,393)             (2,393)
Non-cash compensation 1,108     1,108        
Net settlement of vested stock awards (in shares)     1          
Net settlement of vested stock awards (1)     (1)        
Ending balance (in shares) at Sep. 30, 2021     30,980          
Ending balance at Sep. 30, 2021 75,437   $ 9,289 428,031   (332,531)   (29,352)
Beginning balance (in shares) at Dec. 31, 2021     31,215          
Beginning balance at Dec. 31, 2021 51,867 $ (1,827) $ 9,359 444,824 $ (5,651) (375,584) $ 3,824 (26,732)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net loss (32,462)         (32,462)    
Issuance of common stock (in shares)     11,905          
Issuance of common stock 9,768   $ 3,572 6,196        
Foreign currency translation adjustment, net of tax 346             346
Non-cash compensation (in shares)     2          
Non-cash compensation (624)     (624)        
Net settlement of vested stock awards 2     2        
Ending balance (in shares) at Mar. 31, 2022     43,122          
Ending balance at Mar. 31, 2022 $ 27,070   $ 12,931 444,747   (404,222)   (26,386)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Adjustments for prior periods from adopting ASU 2020-06 ASU 2020-06 (ASC 470-20)              
Beginning balance (in shares) at Dec. 31, 2021     31,215          
Beginning balance at Dec. 31, 2021 $ 51,867 $ (1,827) $ 9,359 444,824 $ (5,651) (375,584) $ 3,824 (26,732)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net loss [1] (76,887)              
Ending balance (in shares) at Sep. 30, 2022     43,224          
Ending balance at Sep. 30, 2022 (28,730)   $ 12,962 445,839   (448,647)   (38,884)
Beginning balance (in shares) at Mar. 31, 2022     43,122          
Beginning balance at Mar. 31, 2022 27,070   $ 12,931 444,747   (404,222)   (26,386)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net loss (21,552)         (21,552)    
Issuance of common stock (in shares)     102          
Issuance of common stock (71)   $ 31 (102)        
Foreign currency translation adjustment, net of tax (5,463)             (5,463)
Non-cash compensation 565     565        
Ending balance (in shares) at Jun. 30, 2022     43,224          
Ending balance at Jun. 30, 2022 549   $ 12,962 445,210   (425,774)   (31,849)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net loss (22,873)              
Foreign currency translation adjustment, net of tax (7,035)              
Non-cash compensation 629     629        
Ending balance (in shares) at Sep. 30, 2022     43,224          
Ending balance at Sep. 30, 2022 $ (28,730)   $ 12,962 $ 445,839   $ (448,647)   $ (38,884)
[1] Condensed consolidated statements of cash flows include discontinued operations.
September 30, 2022September 30, 2021
Cash and cash equivalents from continuing operations$56,387 $12,009 
Cash and cash equivalents from discontinued operations10,641 4,963 
Total$67,028 $16,972